A detailed history of Pictet Asset Management Holding Sa transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 304,705 shares of DYN stock, worth $7.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
304,705
Previous 294,748 3.38%
Holding current value
$7.29 Million
Previous $10.4 Million 5.23%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$31.94 - $47.04 $318,026 - $468,377
9,957 Added 3.38%
304,705 $10.9 Million
Q2 2024

Aug 13, 2024

BUY
$23.65 - $35.63 $6.97 Million - $10.5 Million
294,748 New
294,748 $10.4 Million

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.